Detection of blaTEM, blaSHV, and blaCTX-M genes among the Extended-Spectrum β-Lactamases (ESβLs) producing Enterobacteriaceae isolated from hospital-acquired infections and community in Egypt
Abstract
Background: Bacteria are resistant to an antibiotic such as Escherichia coli, Klebsiella pneumonia, and Enterobacter sp. responsible for morbidity in worldwide. ESβLs are a group of plasmids encoded enzymes that have the efficacy to hydrolyze β-lactams antibiotics. The spread of (ESβLs) representing a serious problem and threatening the ability to treat an infection. Aim of the study: This study aimed to investigate ESβLs-producing Enterobacteriaceae sp. isolated from patients and healthy individuals and detect the resistant genes blaTEM, blaSHV, and blaCTX-M. Patients and Methods: Two hundred bacterial isolates were recovered from patients and healthy individuals rectal swab samples. These isolates were screened for producing ESβLs and identified using both standard bacteriological methods and VITEK2 compact system). The antibiotics resistance of Enterobacteriaceae was assessed by the disk diffusion method and detection of blaTEM, blaSHV, and blaCTX-M genes by multiplex PCR. Results: Two hundred Enterobacteriaceae screening for-producing ESβLs showed that 56% (112/200) produce ESβLs. One hundred and twelve ESβLs-Enterobacteriaceae identified as following, Klebsiella pneumonia 51.73% (58/112), Escherichia coli and 46.40% (52/112), and Enterobacter cloacae 1.80% (2/112). The antibiotic resistance patterns of Enterobacteriaceae showed high resistance to ciprofloxacin, levofloxacin, and amikacin with the ratio of (71.76%), (60.72%) and (60.72%), respectively. Furthermore, ESβLs…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.